Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000192721 | SCV000246419 | uncertain significance | not specified | 2015-05-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004649090 | SCV005143920 | uncertain significance | Inborn genetic diseases | 2024-03-19 | criteria provided, single submitter | clinical testing | The c.1933G>A (p.D645N) alteration is located in exon 17 (coding exon 17) of the AP3B1 gene. This alteration results from a G to A substitution at nucleotide position 1933, causing the aspartic acid (D) at amino acid position 645 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Center for Genomic Medicine, |
RCV004760424 | SCV005374169 | uncertain significance | Hermansky-Pudlak syndrome 2 | 2024-09-22 | criteria provided, single submitter | clinical testing |